MLN-133

N/A

Report date: 2022/05/10 11:40:27
NME

Base Information

Drug NameMLN-133
Drug Alias NameMLN133
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCNBX Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCNBX Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A